Trials / Unknown
UnknownNCT01193504
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Innovative Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine if Lotemax eye drops are at least as effective as Pred Forte eye drops, which are the standard of care after cataract surgery.
Detailed description
Prednisolone 1%, a topical steroid, is considered standard of care following cataract surgery to reduce inflammation. We aim to determine if Lotemax is at least as effective as Prednisolone. If so, these findings would demonstrate that physicians have other treatment options to consider.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pred Forte | Pred Forte BID for 4 weeks postop |
| DRUG | Lotemax | Lotemax BID for 4 weeks postop. |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2010-09-02
- Last updated
- 2012-06-14
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01193504. Inclusion in this directory is not an endorsement.